SPDR Series Trust SPDR S&P Biotech ETF (XBI)
86.24
-1.06 (-1.21%)

The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital.
Via MarketBeat · September 23, 2024

The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors.
Via MarketBeat · July 13, 2023

Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSELABU) if you want a speculative play in the biotechnology industry with amplified volatility.
Via MarketBeat · March 22, 2023